Workshop: Extended-Release Buprenorphine for Vulnerable Populations with Opioid Use Disorder: Clinical Challenges, Pharmacokinetics, and Outcomes-Extended-Release Buprenorphine for Vulnerable Populations with Opioid Use Disorder: Clinical Challenges, Pharmacokinetics, and Outcomes

Extended-Release Buprenorphine for Vulnerable Populations with Opioid Use Disorder: Clinical Challenges, Pharmacokinetics, and Outcomes

Back to course

Video Transcription

Video Summary

The video summarizes the preliminary findings of a study on the use of extended-release buprenorphine for opioid use disorder treatment in vulnerable populations. The study found that the majority of participants did not reach the target concentration of buprenorphine in their blood, indicating low levels of the medication. Those who did reach the target threshold had lower levels of heroin and fentanyl use and reported reduced craving and withdrawal symptoms. However, there was considerable variability in the blood levels achieved. The video discusses the implications of these findings, including the need for individualized treatment and considerations regarding high-potency opioids like fentanyl. The panelists also emphasize the importance of addressing patient concerns and the need for further research to understand the relationship between blood levels, medication effectiveness, and factors like inflammation and co-occurring infections. The video also explores the challenges of pain management for patients on buprenorphine and the need for personalized dosing and evidence-based practices. Overall, the discussion highlights the importance of a patient-centered approach to buprenorphine treatment and the need for more research to guide dosing decisions.

Keywords

extended-release buprenorphine

opioid use disorder treatment

vulnerable populations

target concentration

medication levels

heroin use

fentanyl use

craving and withdrawal symptoms

individualized treatment

high-potency opioids

patient concerns

inflammation

research

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events